Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 4
2012 3
2013 1
2014 6
2015 4
2017 2
2018 1
2019 4
2020 2
2021 2
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Genomic medicine advances for brain tumors.
Koizumi S, Oishi T, Iwaizumi M, Kurozumi K. Koizumi S, et al. Int J Clin Oncol. 2024 May 10. doi: 10.1007/s10147-024-02522-2. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38727852 Review.
Mesenchymal stem cells as therapeutic vehicles for glioma.
Oishi T, Koizumi S, Kurozumi K. Oishi T, et al. Among authors: koizumi s. Cancer Gene Ther. 2024 Apr 23. doi: 10.1038/s41417-024-00775-7. Online ahead of print. Cancer Gene Ther. 2024. PMID: 38654128 Review.
The present indication and future of deep brain stimulation.
Sugiyama K, Nozaki T, Asakawa T, Koizumi S, Saitoh O, Namba H. Sugiyama K, et al. Among authors: koizumi s. Neurol Med Chir (Tokyo). 2015;55(5):416-21. doi: 10.2176/nmc.ra.2014-0394. Epub 2015 Apr 28. Neurol Med Chir (Tokyo). 2015. PMID: 25925757 Free PMC article. Review.
Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
Yamasaki F, Fudaba H, Asano K, Sasayama T, Natsumeda M, Shimabukuro T, Taguchi K, Koizumi S, Nakayama N, Fujii K, Nishibuchi I, Sugiyama K, Yoshida K, Yonezawa U, Yasutomo M, Kawasaki Y, Kakuta K, Katayama K, Tanaka K, Nagashima H, Tsukamoto Y, Ideguchi M, Nishizaki T, Kurozumi K, Hosoya T, Akita T, Kambe A. Yamasaki F, et al. Among authors: koizumi s. BMJ Open. 2023 Apr 24;13(4):e071350. doi: 10.1136/bmjopen-2022-071350. BMJ Open. 2023. PMID: 37094899 Free PMC article.
[Gene Therapy and Viral Therapy for Malignant Glioma].
Kurozumi K, Koizumi S, Otani Y. Kurozumi K, et al. Among authors: koizumi s. No Shinkei Geka. 2021 May;49(3):608-616. doi: 10.11477/mf.1436204434. No Shinkei Geka. 2021. PMID: 34092566 Japanese.
Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases.
Oishi T, Ito M, Koizumi S, Horikawa M, Yamamoto T, Yamagishi S, Yamasaki T, Sameshima T, Suzuki T, Sugimura H, Namba H, Kurozumi K. Oishi T, et al. Among authors: koizumi s. Mol Ther Methods Clin Dev. 2022 Jul 6;26:253-265. doi: 10.1016/j.omtm.2022.07.001. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 35892087 Free PMC article.
36 results